Searched for
DIVALPROEX SODIUM
Sun Pharma, Lupin, Dr Reddy's recall products in US market due to manufacturing issuesThree major Indian pharmaceutical companies are recalling drugs in the United States. Sun Pharma is recalling Lisdexamfetamine capsules due...- Govt bans 156 medicines including antibiotics, painkillers, multivitamins: Here is the full listThe Ministry of Health and Family Welfare has banned the manufacture, sale, and distribution of 156 fixed dose combinations. These include ...
- Manufacturing issues led drug makers Glenmark, Sun Pharma, Dr Reddy's to recall products in USAs per the US health regulator, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may caus...
- Lupin gets USFDA nod to market its mania and epilepsy treatment drug in USThe company has received approval from the United States Food and Drug Administration (USFDA) for its Divalproex Sodium extended-release ta...
- Taro drug pricing probe may widen to other generic drug makersResearch by IIFL shows several generic drug companies, including a few top Indian generic drug makers, effected steep price increases withi...
- Dr Reddy's Laboratories recalls anti-seizure, hypertension drugs from US marketThe firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests.
- US legal authorities seek information on Dr Reddy's Laboratories drug pricing mechanismAttorney Generals of Texas and California have separately sought information on pricing of some drugs sold by Dr Reddy's Laboratories in th...
- Aurobindo gets USFDA nod to market mental illness drugAccording to IMS sales data, the product had a market size of around USD 690 million for the twelve months ended March 2014.
- Analysts see over 20% upside in Cadila Healthcare after strong Q3 showGiven the overall technical picture, there is a strong possibility of a price breakout occurring at the end of February 2014.
- Aurobindo Pharma gets USFDA approval for CNS drugAurobindo Pharma said it has received US health regulator's approval to manufacture and sell generic Divalproex Sodium Delayed-Release tabl...
- Unichem gets USFDA nod for Divalproex; stocks upUnichem Laboratories has received approval from USFDA for Divalproex Sodium delayed release tablets USP 125mg, 250mg and 500mg.
- Orchid Chemicals gets USFDA approval for divalproex tabletsOrchid Chemicals & Pharmaceuticals has received US Food and Drug Administration approval for its abbreviated new drug application for dival...
- Sun Pharma gets approval form USFDA for Depakote TabletSun Pharmaceutical has received tentative approval for the abbreviated new drug application--generic Depakote , divalproex sodium delayed r...
- Abbott files patent suit against Zydus Cadila in US courtUS-based Abbott Laboratories seeks to stop the Indian company, Zydus Cadila, from selling generic version of its drug, Depakote, in the US.
- Cadila bags USFDA nod for 3 productsPharmaceutical firm, Cadila Healthcare today said USFDA has given its nod it for the company's three products, taking the group's total num...
- New drug dose helps local firms regain health in USDomestic pharma majors are witnessing sharp recovery in their US business.
- Wockhardt gets nod for new drugWockhardt Ltd has received tentative approval from the USFDA for anti-epileptic drug, Divalproex Sodium delayed-release tablets.
Load More
